CompuGroup Medical SE & Co. KGaA
CMPVF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.17 | -0.11 | 0.20 | -0.65 |
| FCF Yield | 0.83% | 6.35% | 1.07% | 1.85% |
| EV / EBITDA | 38.86 | 37.66 | 47.81 | 31.61 |
| Quality | ||||
| ROIC | 3.88% | 0.95% | -3.44% | 0.00% |
| Gross Margin | 23.55% | 84.49% | 82.41% | 84.02% |
| Cash Conversion Ratio | 2.99 | 8.50 | -4.08 | 3.60 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.26% | -1.33% | 0.27% | 2.07% |
| Free Cash Flow Growth | -86.95% | 681.51% | -42.10% | 182.37% |
| Safety | ||||
| Net Debt / EBITDA | 15.73 | 13.73 | 21.66 | 14.36 |
| Interest Coverage | 12.37 | 2.59 | 12.79 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 14.37 | 2.95 | 3.69 | 2.43 |
| Cash Conversion Cycle | 42.76 | -68.62 | -71.52 | -50.29 |